Close Menu

NEW YORK – Pattern Bioscience said on Tuesday that it has raised $9 million in additional Series B-1 funding to accelerate the development and clinical validation of its Digital Culture rapid bacterial identification and susceptibility testing technology.

Illumina Ventures led the round, joined by Omnimed Capital, the lead investor in the company's previous two funding rounds.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.